INTANGIBLE ASSETS (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
INTANGIBLE ASSETS (Details Narrative) - USD ($)	Oct. 12, 2018	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Intangible assets, gross		$ 3,176,700		$ 15,200
Accumulated amortization		(28,431)		(7,352)
Naltrexone Implant Formulation [Member] \| Australia from Trinity Compound Solutions [Member]
Patent acquired	$ 15,200
Estimated useful lives	13 years
Customer Base [Member]
Intangible assets, gross		2,709,500		0
Accumulated amortization		20,785
Amortization expense		20,785
Intellectual Property [Member]
Amortization expense		294	$ 294
Accumulated amortization		7,646
Trademarks [Member]
Intangible assets, gross		$ 452,000		$ 0